Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: A comprehensive clinical evaluation

Divya N. Challa, Zoran Kvrgic, Andrea L Cheville, Cynthia Crowson, Tim Bongartz, Thomas Mason, Eric Lawrence Matteson, Clement Michet, Scott T. Persellin, Daniel E. Schaffer, Theresa L.Wampler Muskardin, Kerry Wright, John Manley III Davis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Discordance between patients with rheumatoid arthritis (RA) and their rheumatology health care providers is a common and important problem. The objective of this study was to perform a comprehensive clinical evaluation of patient-provider discordance in RA. Methods: A cross-sectional observational study was conducted of consecutive RA patients in a regional practice with an absolute difference of≥25 points between patient and provider global assessments (possible points, 0-100). Data were collected for disease activity measures, clinical characteristics, comorbidities, and medications. In a prospective substudy, participants completed patient-reported outcome measures and underwent ultrasonographic assessment of synovial inflammation. Differences between the discordant and concordant groups were tested using χ2 and rank sum tests. Multivariable logistic regression was used to develop a clinical model of discordance. Results: Patient-provider discordance affected 114 (32.5%) of 350 consecutive patients. Of the total population, 103 patients (29.5%) rated disease activity higher than their providers (i.e., 'positive' discordance); only 11 (3.1%) rated disease activity lower than their providers and were excluded from further analysis. Positive discordance correlated with negative rheumatoid factor and anticyclic citrullinated peptide antibodies, lack of joint erosions, presence of comorbid fibromyalgia or depression, and use of opioids, antidepressants, or anxiolytics, or fibromyalgia medications. In the prospective study, the group with positive discordance was distinguished by higher pain intensity, neuropathic type pain, chronic widespread pain and associated polysymptomatic distress, and limited functional health status. Depression was found to be an important mediator of positive discordance in low disease activity whereas the widespread pain index was an important mediator of positive discordance in moderate-to-high disease activity states. Ultrasonography scores did not reveal significant differences in synovial inflammation between discordant and concordant groups. Conclusions: The findings provide a deeper understanding of patient-provider discordance than previously known. New insights from this study include the evidence that positive discordance is not associated with unrecognized joint inflammation by ultrasonography and that depression and fibromyalgia appear to play distinct roles in determining positive discordance. Further work is necessary to develop a comprehensive framework for patient-centered evaluation and management of RA and associated comorbidities in patients in the scenario of patient-provider discordance.

Original languageEnglish (US)
Article number212
JournalArthritis Research and Therapy
Volume19
Issue number1
DOIs
StatePublished - Sep 26 2017

Fingerprint

Rheumatoid Arthritis
Fibromyalgia
Depression
Inflammation
Comorbidity
Ultrasonography
Joints
Pain
Rheumatoid Factor
Anti-Anxiety Agents
Rheumatology
Neuralgia
Nonparametric Statistics
Chronic Pain
Health Personnel
Opioid Analgesics
Antidepressive Agents
Health Status
Observational Studies
Cross-Sectional Studies

Keywords

  • Depression
  • Disease activity
  • Fibromyalgia
  • Patient-reported outcomes
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis : A comprehensive clinical evaluation. / Challa, Divya N.; Kvrgic, Zoran; Cheville, Andrea L; Crowson, Cynthia; Bongartz, Tim; Mason, Thomas; Matteson, Eric Lawrence; Michet, Clement; Persellin, Scott T.; Schaffer, Daniel E.; Muskardin, Theresa L.Wampler; Wright, Kerry; Davis, John Manley III.

In: Arthritis Research and Therapy, Vol. 19, No. 1, 212, 26.09.2017.

Research output: Contribution to journalArticle

@article{7e3edc0c359145359db77ea9d0555c7f,
title = "Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: A comprehensive clinical evaluation",
abstract = "Background: Discordance between patients with rheumatoid arthritis (RA) and their rheumatology health care providers is a common and important problem. The objective of this study was to perform a comprehensive clinical evaluation of patient-provider discordance in RA. Methods: A cross-sectional observational study was conducted of consecutive RA patients in a regional practice with an absolute difference of≥25 points between patient and provider global assessments (possible points, 0-100). Data were collected for disease activity measures, clinical characteristics, comorbidities, and medications. In a prospective substudy, participants completed patient-reported outcome measures and underwent ultrasonographic assessment of synovial inflammation. Differences between the discordant and concordant groups were tested using χ2 and rank sum tests. Multivariable logistic regression was used to develop a clinical model of discordance. Results: Patient-provider discordance affected 114 (32.5{\%}) of 350 consecutive patients. Of the total population, 103 patients (29.5{\%}) rated disease activity higher than their providers (i.e., 'positive' discordance); only 11 (3.1{\%}) rated disease activity lower than their providers and were excluded from further analysis. Positive discordance correlated with negative rheumatoid factor and anticyclic citrullinated peptide antibodies, lack of joint erosions, presence of comorbid fibromyalgia or depression, and use of opioids, antidepressants, or anxiolytics, or fibromyalgia medications. In the prospective study, the group with positive discordance was distinguished by higher pain intensity, neuropathic type pain, chronic widespread pain and associated polysymptomatic distress, and limited functional health status. Depression was found to be an important mediator of positive discordance in low disease activity whereas the widespread pain index was an important mediator of positive discordance in moderate-to-high disease activity states. Ultrasonography scores did not reveal significant differences in synovial inflammation between discordant and concordant groups. Conclusions: The findings provide a deeper understanding of patient-provider discordance than previously known. New insights from this study include the evidence that positive discordance is not associated with unrecognized joint inflammation by ultrasonography and that depression and fibromyalgia appear to play distinct roles in determining positive discordance. Further work is necessary to develop a comprehensive framework for patient-centered evaluation and management of RA and associated comorbidities in patients in the scenario of patient-provider discordance.",
keywords = "Depression, Disease activity, Fibromyalgia, Patient-reported outcomes, Rheumatoid arthritis",
author = "Challa, {Divya N.} and Zoran Kvrgic and Cheville, {Andrea L} and Cynthia Crowson and Tim Bongartz and Thomas Mason and Matteson, {Eric Lawrence} and Clement Michet and Persellin, {Scott T.} and Schaffer, {Daniel E.} and Muskardin, {Theresa L.Wampler} and Kerry Wright and Davis, {John Manley III}",
year = "2017",
month = "9",
day = "26",
doi = "10.1186/s13075-017-1419-5",
language = "English (US)",
volume = "19",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis

T2 - A comprehensive clinical evaluation

AU - Challa, Divya N.

AU - Kvrgic, Zoran

AU - Cheville, Andrea L

AU - Crowson, Cynthia

AU - Bongartz, Tim

AU - Mason, Thomas

AU - Matteson, Eric Lawrence

AU - Michet, Clement

AU - Persellin, Scott T.

AU - Schaffer, Daniel E.

AU - Muskardin, Theresa L.Wampler

AU - Wright, Kerry

AU - Davis, John Manley III

PY - 2017/9/26

Y1 - 2017/9/26

N2 - Background: Discordance between patients with rheumatoid arthritis (RA) and their rheumatology health care providers is a common and important problem. The objective of this study was to perform a comprehensive clinical evaluation of patient-provider discordance in RA. Methods: A cross-sectional observational study was conducted of consecutive RA patients in a regional practice with an absolute difference of≥25 points between patient and provider global assessments (possible points, 0-100). Data were collected for disease activity measures, clinical characteristics, comorbidities, and medications. In a prospective substudy, participants completed patient-reported outcome measures and underwent ultrasonographic assessment of synovial inflammation. Differences between the discordant and concordant groups were tested using χ2 and rank sum tests. Multivariable logistic regression was used to develop a clinical model of discordance. Results: Patient-provider discordance affected 114 (32.5%) of 350 consecutive patients. Of the total population, 103 patients (29.5%) rated disease activity higher than their providers (i.e., 'positive' discordance); only 11 (3.1%) rated disease activity lower than their providers and were excluded from further analysis. Positive discordance correlated with negative rheumatoid factor and anticyclic citrullinated peptide antibodies, lack of joint erosions, presence of comorbid fibromyalgia or depression, and use of opioids, antidepressants, or anxiolytics, or fibromyalgia medications. In the prospective study, the group with positive discordance was distinguished by higher pain intensity, neuropathic type pain, chronic widespread pain and associated polysymptomatic distress, and limited functional health status. Depression was found to be an important mediator of positive discordance in low disease activity whereas the widespread pain index was an important mediator of positive discordance in moderate-to-high disease activity states. Ultrasonography scores did not reveal significant differences in synovial inflammation between discordant and concordant groups. Conclusions: The findings provide a deeper understanding of patient-provider discordance than previously known. New insights from this study include the evidence that positive discordance is not associated with unrecognized joint inflammation by ultrasonography and that depression and fibromyalgia appear to play distinct roles in determining positive discordance. Further work is necessary to develop a comprehensive framework for patient-centered evaluation and management of RA and associated comorbidities in patients in the scenario of patient-provider discordance.

AB - Background: Discordance between patients with rheumatoid arthritis (RA) and their rheumatology health care providers is a common and important problem. The objective of this study was to perform a comprehensive clinical evaluation of patient-provider discordance in RA. Methods: A cross-sectional observational study was conducted of consecutive RA patients in a regional practice with an absolute difference of≥25 points between patient and provider global assessments (possible points, 0-100). Data were collected for disease activity measures, clinical characteristics, comorbidities, and medications. In a prospective substudy, participants completed patient-reported outcome measures and underwent ultrasonographic assessment of synovial inflammation. Differences between the discordant and concordant groups were tested using χ2 and rank sum tests. Multivariable logistic regression was used to develop a clinical model of discordance. Results: Patient-provider discordance affected 114 (32.5%) of 350 consecutive patients. Of the total population, 103 patients (29.5%) rated disease activity higher than their providers (i.e., 'positive' discordance); only 11 (3.1%) rated disease activity lower than their providers and were excluded from further analysis. Positive discordance correlated with negative rheumatoid factor and anticyclic citrullinated peptide antibodies, lack of joint erosions, presence of comorbid fibromyalgia or depression, and use of opioids, antidepressants, or anxiolytics, or fibromyalgia medications. In the prospective study, the group with positive discordance was distinguished by higher pain intensity, neuropathic type pain, chronic widespread pain and associated polysymptomatic distress, and limited functional health status. Depression was found to be an important mediator of positive discordance in low disease activity whereas the widespread pain index was an important mediator of positive discordance in moderate-to-high disease activity states. Ultrasonography scores did not reveal significant differences in synovial inflammation between discordant and concordant groups. Conclusions: The findings provide a deeper understanding of patient-provider discordance than previously known. New insights from this study include the evidence that positive discordance is not associated with unrecognized joint inflammation by ultrasonography and that depression and fibromyalgia appear to play distinct roles in determining positive discordance. Further work is necessary to develop a comprehensive framework for patient-centered evaluation and management of RA and associated comorbidities in patients in the scenario of patient-provider discordance.

KW - Depression

KW - Disease activity

KW - Fibromyalgia

KW - Patient-reported outcomes

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85029893495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029893495&partnerID=8YFLogxK

U2 - 10.1186/s13075-017-1419-5

DO - 10.1186/s13075-017-1419-5

M3 - Article

C2 - 28950896

AN - SCOPUS:85029893495

VL - 19

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 1

M1 - 212

ER -